The role of dysbiosis in food allergy (FA) remains unclear. We found that dysbiotic fecal microbiota in FA infants evolved compositionally over time and failed to protect against FA in mice. Infants and mice with FA had decreased IgA and increased IgE binding to fecal bacteria, indicative of a broader breakdown of oral tolerance than hitherto appreciated. Therapy with Clostridiales species impacted by dysbiosis, either as a consortium or as monotherapy with Subdoligranulum variabile, suppressed FA in mice as did a separate immunomodulatory Bacteroidales consortium. Bacteriotherapy induced expression by regulatory T (Treg) cells of the transcription factor ROR-γt in a MyD88-dependent manner, which was deficient in FA infants and mice and ineffectively induced by their microbiota. Deletion of Myd88 or Rorc in Treg cells abrogated protection by bacteriotherapy. Thus, commensals activate a MyD88/ROR-γt pathway in nascent Treg cells to protect against FA, while dysbiosis impairs this regulatory response to promote disease.
F
A is a major public health concern 1 . Most FA is acquired in the first years of life, indicating a critical role for early childhood exposures in disease pathogenesis. Factors impacting the gut microbiota, including method of delivery, antibiotic use and breastfeeding, influence the development of atopic disease [2] [3] [4] [5] [6] . Reduced bacterial diversity and an increased Enterobacteriaceae/ Bacteroidaceae ratio in infancy have been associated with food sensitization, suggesting a role for altered gut microbiota in FA 7 . Experimentally, germ-free (GF) mice cannot be orally tolerized to innocuous antigens and have reduced gut IgA and decreased interleukin (IL)-10-producing regulatory T (Treg) cells [8] [9] [10] . Antibiotic treatment also increases food allergen sensitization 11 . In contrast, colonization of GF mice with extended consortia of Clostridia species induces Treg cells 12 and protects against FA 11 . Mice genetically prone to FA (Il4ra F709 mice) exhibit dysbiotic fecal flora that promote FA 13 . Commensals may suppress FA by producing short-chain fatty acids (SCFA), which elicit protective mucosal Treg cell responses and enhance intestinal barrier integrity [14] [15] [16] [17] [18] [19] [20] . Here, we identify an evolving dysbiosis in the gut microbiota of infants with FA that impairs their capacity to protect against FA. Bacteriotherapy with culturable human-origin species from the order Clostridiales or Bacteroidales prevents FA and suppresses established disease in Il4ra F709 mice. Bacteriotherapy activates a MyD88-dependent microbial-sensing pathway in nascent Treg cells that gives rise to disease-suppressing ROR-γt + Treg cells 21, 22 , which are deficient in both subjects with FA and mice due to dysbiosis. These results identify a shared regulatory mechanism by which different commensals suppress FA, and underscore the potential for microbial therapies in treating this disorder.
Results

Patients with FA manifest early onset dynamic gut dysbiosis.
We analyzed the fecal microbiota of 56 infants with FA and 98 agematched controls recruited at 1-15 months of age, and periodically sampled every 4-6 months for up to 30 months of age. Supplementary  Table 1 summarizes subject demographics, and Supplementary Fig. 1a summarizes the distribution of samples collected by subject age. Food allergy versus healthy control (HC) subjects demonstrated no significant differences in the overall ecological diversity of the fecal microbiota as assessed by measures of alpha and beta diversity ( Supplementary  Fig. 1b,c) . However, compositional differences in relative abundance among 77 operational taxonomic units (OTUs) were observed in the fecal microbiome between age-stratified subjects with FA and controls (false discovery rate-adjusted P < 0.1) ( Fig. 1 and Supplementary Table 2 ). Differences for some taxa, such as OTU 50 (closest reference species (CRS) Subdoligranulum variabile), occurred across several age groups, while other taxa, including several Clostridiales species (clusters I, IV, XI and XIVa), showed significant differences in specific age groups. These associations in patients with FA occurred even when controlling for factors including gender, mode of delivery for all age groups, and breastfeeding until 18 months of age, using multivariate statistical models. We also compared the gut microbiota of control subjects who were consuming milk products to those of patients with FA who were tolerant and consuming milk but were allergic to other foods. When thus controlled for milk avoidance, most of the dysbiotic changes persisted (Supplementary Fig. 2 and Supplementary Table 3 ).
The microbiota of subjects with FA fails to protect against FA in a mouse disease model. To assess the functional significance of Articles Nature MediciNe dysbiosis in FA, adult GF Il4ra F709 mice that were either left uncolonized or that received fecal microbiota transplants (FMT) from HC or infants with FA were sensitized with chicken egg ovalbumin (OVA) along with the mucosal adjuvant staphylococcal enterotoxin B (SEB), and subsequently challenged with OVA 13, [23] [24] [25] . GF Il4ra F709 mice, or those that received FMT from infants with FA, exhibited a rapid and sustained drop in their core body temperature indicative of anaphylaxis, whereas mice that received donor microbiota from HC had a mild, transient drop (Fig. 1e) . While the total serum IgE concentrations across the three groups were similar, induction of OVA-specific IgE was markedly decreased in mice receiving donor microbiota from HC subjects as compared to those receiving donor microbiota from subjects with FA or that remained GF (Fig. 1f) . Also, the increase in serum mouse mast cell protease-1 (MMCP-1) concentrations post-anaphylaxis was notably higher in Il4ra F709 mice that were either GF or had received FMT from subjects with FA as compared to those that had received FMT from healthy subjects (Fig. 1g) . Thus, the capacity of the gut microbiota to protect against FA was profoundly impaired in subjects with FA as compared to HC. Il4ra F709 mice also exhibit dysbiotic microbiota which, following transfer into GF wild-type (WT) BALB/c mice, heightens their susceptibility to FA 13 . We analyzed the capacity of microbiota derived from specific pathogen-free (SPF) WT mice, which are relatively Table 1 . Taxa represented included those from the order Clostridiales, family Lachnospiraceae (a), order Clostridiales, other families (b), order Bacteroidales (c) and miscellaneous taxa (d). Blue represents higher abundance in control subjects, and red represents higher abundance in subjects with FA. Taxonomic information is on the right side of the respective panel. e, Core body temperature changes in GF Il4ra F709 mice that were left uncolonized or reconstituted with FMT from HC or subjects with FA, then sensitized with OVA/SEB and challenged with OVA (n = 7 per group; each recipient mouse received FMT from one HC or a subject with FA). P values were derived by two-way analysis of variance (ANOVA) with Sidak post hoc analysis. f,g, Total (f) and OVA-specific (g) serum IgE concentrations (n = 7 per group, as in e). h, MMCP-1 concentrations (n = 7 per group, as in e). Results represent mean ± s.e.m. from two or three independent experiments. Each symbol represents one subject or mouse. For f-h, P values were derived by one-way ANOVA with Dunnett's post hoc analysis.
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Nature MediciNe resistant to FA induction, to rescue the FA phenotype of Il4ra F709 mice. GF Il4ra F709 mice that were reconstituted by FMT from WT mice, then sensitized with OVA/SEB and challenged with OVA, were protected from FA. In contrast, those reconstituted with SPF Il4ra F709 mouse microbiota developed robust disease, as evidenced by a precipitous drop in core body temperature and increased serum MMCP-1 concentrations post-anaphylaxis, with increased total and OVA-specific serum IgE concentrations (Extended data Fig. 1 ). These results confirmed that dysbiosis promotes FA in both human subjects and mice.
Dysbiosis in FA is associated with an altered immune response to the gut microbiota. Secretory IgA (sIgA) shapes the composition of the microbiota and reinforces commensalism [26] [27] [28] [29] [30] . We analyzed, by flow cytometry, the binding of sIgA to the fecal flora of subjects with FA and HC. The gating strategy for immunoglobulin staining of human fecal flora is demonstrated in Extended data Fig. 2a ,b. Subjects with FA displayed decreased sIgA binding of their fecal bacteria as compared to HC (Fig. 2a,b) . We further explored the hypothesis that FA involves dysregulated allergic responses to both food and bacteria by analyzing IgE binding to the fecal microbiota, which was found increased in subjects with FA as compared to HC, indicative of an allergic response against commensals (Fig. 2c,d ).
We then analyzed the binding of sIgA and IgE to the fecal bacteria of Il4ra F709 mice, following gating strategies shown in Extended data Fig. 2c,d (refs. 13, [23] [24] [25] 31 ). Il4ra F709 and control WT mice were either sham-sensitized with phosphate buffered saline (PBS) or orally sensitized with OVA/SEB and subsequently challenged with OVA. OVA-sensitized Il4ra
F709
, but not WT control mice, exhibited a rapid drop in core body temperature consistent with anaphylaxis ( Fig. 2e) . Similar to subjects with FA, the fecal bacteria of OVAsensitized Il4ra F709 mice exhibited decreased sIgA binding as compared to similarly sensitized WT mice or sham-sensitized Il4ra and WT mice (Fig. 2f,g ). In addition, sensitization with OVA also resulted in increased IgE binding to fecal bacteria of Il4ra F709 mice, but not of WT controls (Fig. 2h,i) . These results were further confirmed by the lack of sIgA or IgE binding to fecal bacteria of Rag2-deficient mice, which do not express immunoglobulins, and the lack of IgE binding to the fecal bacteria of double-mutant Igh7
mice, which carry a targeted deletion of the IgE heavy-chain gene ( Fig. 2f-i) 
23
. Overall, these results established that dysbiosis in FA is associated with decreased sIgA responses and heightened T helper cell type 2 (Th2)/IgE responses to commensal flora.
A defined consortium of human Clostridiales species promotes tolerance in experimental FA. To test the hypothesis that Clostridiales taxa rendered deficient by dysbiosis contribute to oral tolerance breakdown in FA, we examined the capacity of a defined consortium of six Clostridiales type strains, chosen as representative of Clostridiales clusters impacted by dysbiosis in our human study, to suppress the induction of FA in Il4ra F709 mice (Supplementary Table 4 ). Parameters driving selection of the consortium members included well-characterized genomic and metabolic profiles, previous data of in vivo effects on gut epithelium and/or immunomodulation and ease of culturability. The consortium included Clostridium sardiniense (cluster I, for example OTU 20)
32
, Clostridium leptum (cluster IV, for example OTU 29, 50), Clostridium hiranonis and Clostridium bifermentans (cluster XI, for example OTU 22) 33 , Clostridium scindens (cluster XIVa, for example OTU 11) and Clostridium ramosum (Erysipelatoclostridium ramosum) (cluster XVIII, for example OTU 26) 34, 35 . As a negative control, we employed a consortium of species from gamma and delta Proteobacteria classes, including Escherichia coli, Proteus mirabilis, Klebsiella oxytoca (Gammaproteobacteria; family Enterobacteriaceae) and Bilophila wadsworthia (Deltaproteobacteria; family Desulfovibronaceae) (Supplementary Table 4) . B. wadsworthia was increased early in life in subjects with FA before declining, and E. coli was decreased across multiple time windows (Fig. 1d and Supplementary Fig. 2d ), The two other members of the Proteobacteria consortium have been implicated in gut dysbiosis associated with bowel inflammation 36 . In bacterial reconstitution studies, GF Il4ra F709 mice that were either left sterile or colonized with the Proteobacteria consortium exhibited robust anaphylaxis following OVA/SEB sensitization and OVA challenge, whereas those reconstituted with the Clostridiales consortium were fully protected (Fig. 3a) . Measures of allergic sensitization and anaphylaxis, including the rise in serum concentrations of total and OVA-specific IgE, small intestinal tissue mastocytosis and the increase in serum MMCP-1 concentrations post-anaphylaxis, all of which were elevated in GF and Proteobacteria-supplemented mice, were inhibited by the Clostridiales consortium (Fig. 3b,c) .
Whereas treatment of GF Il4ra F709 mice with either the Clostridiales or Proteobacteria consortium increased the frequencies of CD4
+
Foxp3
+ Treg cells in mesenteric lymph nodes (MLN), only the former consortium boosted the frequencies of induced Treg (iTreg) cells, distinguished by its low expression of the markers Helios and neuropilin-1 (Helios -Nrp1 -), whose specificity is biased towards recognizing gut luminal antigens originating from food or bacteria (Fig. 3d ) [37] [38] [39] . Treatment also increased the frequency of ROR-γt + Treg cells, predominantly iTreg cells with low expression of Helios ( Supplementary Fig. 3 ) [40] [41] [42] [43] . These cells have been implicated in the control of different gut T helper (Th) cell-mediated immune responses (Fig. 3d ) 21, 22, 44 . We previously established that FA induction is associated with the reprogramming of Treg cells into Th2 cell-like cells that promote disease 25, 45 . Consistent with these findings, a subset of MLN Treg cells of sham-and OVA-sensitized GF mice exhibited increased expression of the Th2 master transcription factor GATA3 and the Th2 cytokine IL-4. These Th2 celllike Treg cells appeared to be thymus-derived, as reflected by their Helios high phenotype ( Supplementary Fig. 3 ) [40] [41] [42] [43] . A similar increase in Treg cell IL-4 expression was found in mice colonized with the Proteobacteria consortium (Fig. 3d) . In contrast, the Clostridiales consortium suppressed the Th2 cell-like reprogramming of Treg cells and instead promoted the expression of ROR-γt in Treg cells independent of OVA sensitization, a gut Treg cell phenotype proposed to regulate Th2 cell responses (Fig. 3d) 
21
. Overall, these results established that the Clostridiales consortium could confer protection against FA in GF Il4ra F709 mice independent of other bacterial species.
To determine whether protection by the Clostridiales consortium against FA extended to mice colonized with conventional microbiota, SPF Il4ra F709 mice were treated for one week with antibiotics to create a niche for the therapeutic consortia, then sensitized with OVA/SEB by bacteriotherapy administered in tandem (Fig. 3e) . The Clostridiales consortium completely protected OVA/SEB-sensitized Il4ra F709 mice from developing anaphylaxis following oral challenge with OVA (Fig. 3e) . Total and OVA-specific serum IgE responses, gut tissue mast cell expansion and serum MMCP-1 concentrations post-challenge were also sharply curtailed (Fig. 3f) . In contrast, mice treated with Proteobacteria were not protected. Clostridiales therapy increased Treg cells in the MLN, reflective of increased frequencies of Helios 
Nrp1
-cells (Fig. 3g) . The Clostridiales, but not the Proteobacteria, suppressed the Th2 cell-like reprogramming of gut Treg cells as evidenced by their decreased IL-4 expression, consistent with improved Treg cell function, while increasing the frequencies of the ROR-γt + iTreg cells (Fig. 3g,h and Supplementary  Fig. 3 ). Similar results were found in the small intestinal lamina propria lymphocytes (LPL) of Clostridiales-treated Il4ra F709 mice ( Supplementary Fig. 4 ). Of note, previous antibiotic treatment of the mice markedly improved the therapeutic efficacy of the Clostridiales consortium, suggesting that it might serve to enhance the immunomodulatory functions of the consortium by reducing the abundance of interfering bacteria (Extended data Fig. 3 ).
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Treatment with the Clostridiales, but not the Proteobacteria, consortium resulted in an increased sIgA response to the microbiota (Extended data Fig. 2e ). Reciprocally the Clostridiales, but not the Proteobacteria, consortium suppressed the IgE antibacterial response (Extended data Fig. 2f ). These findings suggested that the Clostridiales consortium normalized the aberrant mucosal immune response to the gut microbiota in FA Il4ra F709 mice.
Of the Clostridial taxa affected by dysbiosis in FA, OTU 50 (CRS S. variabile) stood out as being decreased in subjects with FA aged 1 year and older, including those that were milk tolerant, suggesting that its deficiency may act as a switch for FA. Monobacterial therapy with S. variabile, carried out following the protocol shown in Fig. 3e , protected SPF Il4ra F709 mice from developing FA, albeit less stringently than the Clostridiales consortium, in association with the , and n = 14 HC and n = 13 subjects with FA (d). e, Temperature changes in WT (n = 10 mice per group) and Il4ra F709 mice (n = 7 per group) that were either PBS-or OVA/SEB-sensitized then challenged with OVA. f-i, Flow cytometric analysis and frequencies of IgA (f,g) and IgE (h,i) staining of fecal bacteria from WT and Il4ra F709 mice that were sensitized with PBS (n = 14 and 7 per group, respectively) or OVA/SEB (n = 10 and 14 per group, respectively). Fecal pellets from Rag2 -/-and Igh7 -/-Il4ra F709 mice were used as negative controls for sIgA and IgE staining, respectively. Results represent mean ± s.e.m. from two or three independent experiments. Each symbol represents one subject or mouse. P values were derived by Student's unpaired two-tailed t-test (b,d,i), by repeat measures two-way ANOVA (e) or by one-way ANOVA with Dunnett's post hoc analysis (g). SSC, side scatter.
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Nature MediciNe induction of ROR-γt + iTreg cells (Extended data Fig. 4 ). In contrast, therapy with species that were increased in FA subjects, including CRS B. wadsworthia (OTU 68) and CRS Veillonela ratti (OTU 12) (Fig. 1) , failed to protect Il4ra F709 mice from developing FA (data not shown). Thus, the loss of key immunomodulatory bacteria may promote FA.
We also examined the capacity of the Clostridiales consortium to protect FA induced by epicutaneous sensitization of WT mice with OVA, a model of food sensitization in human subjects with eczema Promotion of oral tolerance in FA by immunomodulatory human Bacteroidales species. To determine whether phylogenetically distinct bacteria could protect against FA, we tested another defined consortium comprising five human-origin immunomodulatory Bacteroidales species, including Bacteroides fragilis, Bacteroides ovatus, Bacteroides vulgatus, Prevotella melaninogenica and Parabacteroides distasonis (OTU 24, CRS P. distasonis) 22, [47] [48] [49] [50] . Treatment with the Bacteroidales consortium completely protected against the induction of FA in GF Il4ra F709 mice following their sensitization with OVA/SEB and challenge with OVA (Extended data Fig. 6a-e) . Furthermore, the Bacteroidales consortium protected SPF Il4ra F709 mice from developing FA when given in tandem during OVA/SEB sensitization (Extended data Fig. 6f-i) . Similar to the Clostridiales consortium, the Bacteroidales consortium increased sIgA binding and suppressed IgE binding to the fecal bacteria of treated FA Il4ra F709 mice (Extended data Fig. 6j ). To determine whether bacteriotherapy could suppress FA once the disease was established, SPF Il4ra F709 mice were sensitized with OVA/SEB and, following a short course of antibiotics, further sensitized for an additional four weeks without or with bacteriotherapy with the respective consortia. The Clostridiales and Bacteroidales, but not the Proteobacteria, prevented the sensitized Il4ra F709 mice from reacting to the OVA challenge (Fig. 4a ). They also suppressed the total and OVA-specific serum IgE responses, the rise in serum MMCP-1 post-anaphylaxis and mast cell expansion (Fig. 4b,c) . While all bacterial consortia increased the frequencies of MLN Treg cells in this disease curative model (Fig. 4d) , only the Clostridiales and Bacteroidales consortia suppressed the FA-associated Treg cell Th2 cell-like reprogramming and increased the frequency of ROR-γt + Treg cells ( Fig. 4d and Supplementary Fig. 3 ).
In vivo Treg cell depletion ablates the protective effects of bacterial therapy in FA. We next examined the role of Treg cells in the protection against FA by the Clostridiales and Bacteroidales consortia using Il4ra
F709
Foxp3
EGFP/DTR+ mice, which express the diphtheria toxin (DT) receptor on their Treg cells, allowing for their depletion following treatment of the mice with DT 24, 51 . In OVA/ SEB-sensitized mice, injection of DT thrice over the final two weeks before challenge with OVA abrogated the protection against anaphylaxis imparted by both consortia (Extended data Fig. 7a-d) . In OVA/SEB-sensitized Il4ra Oral supplementation with SCFA does not protect against FA. We examined the role of SCFA in the protection by the bacterial consortia against FA. WT and Il4ra F709 mice had similar fecal concentrations of acetate, propionate, valerate and isovalerate, while butyrate was increased in Il4ra F709 mice (Extended data Fig. 8a ). Furthermore, there was no clear correlation between SCFA production by the bacterial consortia when introduced into GF Il4ra F709 mice and protection against FA. All three consortia produced similar amounts of acetate. The Bacteroidales consortium selectively produced propionate but not butyrate, as previously reported 52 , while butyrate was low to absent in mice reconstituted with the Clostridiales consortium, reflecting its poor production by certain consortium members (Supplementary Table 5) 35 . The capacity of SCFA to protect against FA in Il4ra F709 mice was tested by supplementing the drinking water with a mixture of acetate, propionate and butyrate, given at 150 mM each throughout the sensitization period. However, SCFA therapy failed to protect the mice against FA (Extended data Fig. 8b,c) . It induced increased numbers of proliferating gut Treg cells in OVA/SEB-sensitized WT but not in Il4ra F709 mice ( Supplementary Fig. 6a-d) . It also failed to increase the frequency of MLN ROR-γt + Treg cells in Il4ra F709 mice (Extended data Fig. 8d) .
We investigated the persistence of consortia species in Il4ra F709 mice by real-time PCR analysis of fecal samples using speciesspecific primers (Supplementary Table 6 ). None of the Clostridial species were detected at baseline, and they were only transiently detected when individually introduced by gavage ( Supplementary  Fig. 7a ). Similarly, they were not detected following bacteriotherapy for FA prevention ( Supplementary Fig. 7b ). The Bacteroidales were also not detected at baseline, but several persisted following a single gavage and also by the end of a FA prevention course, as did some Proteobacteria ( Supplementary Fig. 8 ). Heat inactivation of the Clostridiales and Bacteroidales consortia abrogated protection against FA, indicating a requirement for bacterial viability for therapeutic efficacy ( Supplementary Fig. 9 , data not shown).
Protection against FA by commensal bacteria is dependent on ROR-γt + Treg cells. As both the Clostridiales and Bacteroidales consortia increased the frequencies and numbers of gut ROR-γt
+
Treg cells in Il4ra
F709 mice, we examined the frequencies of circulating ROR-γt + Treg cells in human subjects with FA and found these decreased as compared to atopic subjects without FA or to non-atopics (Fig. 5a,b and Supplementary Table 7 ). In contrast, the frequencies of circulating ROR-γt + T effector (Teff) cells were not significantly different between subjects with FA and HC, and slightly increased in atopics ( Fig. 5c and Extended data Fig. 9a,b) . Similarly, circulating ROR-γt + Treg cells were decreased at steady state in Il4ra F709 mice (Extended data Fig. 9c ). OVA/SEB sensitization did not result in increased induction of ROR-γt + Treg cells in the MLN of FA Il4ra F709 mice as compared to WT controls ( Fig. 5d and Extended data Fig. 9c,d) .
We next examined the consequences of Treg cell-specific deletion of Rorc 44 , which encodes ROR-γt, in promoting FA. Treg cells of Foxp3
YFPCre Rorc ∆/∆ mice were profoundly deficient in ROR-γt expression as compared to those of Foxp3
YFPCre mice, reflecting their specific loss of Rorc messenger RNA (Extended data Fig. 9e-g ). Foxp3
YFPCre Rorc ∆/∆ mice sensitized with OVA/SEB and challenged with OVA developed a vigorous anaphylactic response that was comparable to that of similarly treated Il4ra F709 mice. In contrast, Foxp3
YFPCre mice were resistant to FA induction (Fig. 5g,h ). Also, and similar to Il4ra F709 mice, Foxp3
YFPCre Rorc ∆/∆ mice exhibited decreased sIgA and increased IgE binding to fecal bacteria, consistent with dysregulation of the mucosal immune response (Extended data Fig. 10a-d ), which depleted Rorc mRNA expression specifically in this cell compartment (Extended data Fig. 9g ), abrogated this protection (Fig. 6a-d 
Foxp3
YFPCre Rorc ∆/∆ mice (Fig. 6e,f) , with the latter group exhibiting Th2 cell-like skewing of their gut Treg cells (Extended data Fig. 10e,f) .
MyD88-dependent microbial sensing in nascent Treg cells directs sIgA responses to gut commensals and promotes mucosal tolerance 28 . Treg cell-specific deletion of Myd88 in Il4ra F709 mice (Il4ra
F709
Foxp3
YFPCre Myd88
) abrogated the protection by both the Clostridiales and Bacteroidales consortia against FA, and also their induction of ROR-γt + iTreg cells (Fig. 6g-j) , with the gut Treg cells skewing towards a Th2 cell-like phenotype (Extended data Fig. 10g,h) . These results established a microbiota-responsive MyD88-ROR-γt pathway operative in nascent iTreg cells that mediates the therapeutic effects of bacteriotherapy in FA.
Discussion
Several important aspects of the role of dysbiosis in FA emerged from our studies. First, we have identified dynamic dysbiotic changes in the gut microbiota of FA infants that were pathogenic, evidenced by the failure of the microbiota of infants with FA to protect against FA when introduced in GF Il4ra F709 mice, whereas those of HC did so. In the same model, the dysbiotic microbiota of FA-prone Il4ra F709 mice was also non-protective as compared to that of WT mice, indicating an essential role for dysbiosis in FA.
Oral administration of a defined consortium of six human-origin Clostridiales species, related to taxa impacted by dysbiosis in infants with FA, protected against FA and suppressed established disease in FA-prone Il4ra F709 mice. The Clostridiales consortium also normalized the sIgA and suppressed the IgE responses to the gut commensals. These results are distinguished from previous studies by showing that a much smaller consortium of Clostridiales species acted both to prevent and suppress FA 11, 53 . Intriguingly, monobacterial therapy with S. variabile, a Clostridiales species found deficient in FA subjects aged one year and older, was also protective, indicating that the loss of protective species is a key feature of disease pathogenesis. Critically, protection against FA was also effected by a second, phylogenetically unrelated, consortium of five humanorigin Bacteroidales species. Both consortia required an intact ROR-γt + iTreg cell response for therapeutic efficacy. Though related taxa of Bacteroidales and Clostridales were increased in subjects with FA, the inability of the microbiota of these patients either to protect GF Il4ra F709 mice against FA or to effectively induce ROR-γt Articles Nature MediciNe cell-specific MyD88-dependent pathway plays a requisite role in curtailing FA. Notably, the frequencies of ROR-γt + iTreg cells were decreased in both human FA allergic subjects and FA mice, consistent with their requirement in the mediation of oral tolerance in FA. These results provide a unifying mechanism for disease initiation in FA, involving dysbiotic gut microbiota that fail to induce protective ROR-γt + iTreg cell populations, and they support the use of immunomodulatory bacteria in restoring ROR-γt + iTreg populations and re-establishing tolerance in FA.
Finally, extension of the allergic response in FA to involve the gut microbiota indicates a broader disturbance in oral tolerance than hitherto appreciated. MyD88-dependent signaling in nascent gut YFPCre Rorc ∆/∆ OVA/SEB (n = 6) and Il4ra
F709
Foxp3
YFPCre OVA/SEB (n = 6). j, Frequencies of MLN IL-4
+
Foxp3
+ and GATA3
YFPCre Rorc ∆/∆ OVA/SEB (n = 5) and Il4ra
F709
Foxp3
YFPCre OVA/SEB (n = 6). k, Frequencies of ROR-γt + Foxp3 + T cells in the MLN and small intestinal (gut) LPL of OVA/SEB-sensitized and OVA-challenged GF Il4ra F709 mice without (n = 10) or with FMT from HC or subjects with FA (n = 7 per group). Results represent mean ± s.e.m. from two independent experiments. Each symbol represents one mouse or subject. P values were derived by one-way ANOVA with Dunnett's post hoc analysis (b-d,f,h-k) or by repeat measures two-way ANOVA (e). 
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Il4ra
F709
Foxp3
Il4ra
F709
Foxp3
YFPCre Myd88 Δ/Δ + Bacteroidales YFPCre Rorc ∆/∆ OVA/ SEB (n = 8), OVA/SEB, Clostridiales (n = 6) and OVA/SEB, Bacteroidales (n = 10). b, Total and OVA-specific IgE: Il4ra F709 OVA/SEB (n = 9 and 5), OVA/SEB, Clostridiales (n = 5 per group) and OVA/SEB, Bacteroidales (n = 9 and 8); Il4ra OVA/SEB (n = 6), OVA/SEB, Clostridiales (n = 6) and OVA/SEB, Bacteroidales (n = 6). e,f, Analysis of MLN ROR-γt + Foxp3 + Treg cells, representative of two experiments: Il4ra F709 OVA/SEB (n = 8), OVA/SEB, Clostridiales (n = 5) and OVA/SEB, Bacteroidales (n = 9); Il4ra
F709
Foxp3
YFPCre Rorc ∆/∆ OVA/SEB (n = 5), OVA/SEB, Clostridiales (n = 6) and OVA/SEB, Bacteroidales (n = 6). g, Temperature changes in the following OVA/SEB-sensitized and OVAchallenged mouse groups: Il4ra
F709
Foxp3
YFPCre , Bacteroidales (n = 14) and Il4ra
F709
Foxp3
YFPCre
Myd88
Δ/Δ mice untreated (n = 8) or treated with Clostridiales (n = 7) or Bacteroidales (n = 8). h, Total and OVA-specific IgE and MMCP-1 concentrations: Il4ra
F709
Foxp3
YFPCre , Bacteroidales (n = 9 per group), Il4ra
F709
Foxp3
YFPCre
Myd88
Δ/Δ mice untreated (n = 8 per group) or treated with Clostridiales (n = 7 per group) or Bacteroidales (n = 8 per group). i,j, Analysis of MLN ROR-γt + Foxp3 + Treg cells in the same groups in h. Results represent mean ± s.e.m. from two independent experiments. Each symbol represents one mouse. P values were derived by one-way ANOVA with Dunnett's post hoc analysis (b,d,f,h,j), or by repeat measures two-way ANOVA (a,g).
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Treg cells directs IgA antibody responses to gut luminal antigens, including commensals and foods 28 . The disruption of the MyD88-ROR-γt regulatory axis by dysbiosis in FA gave rise to decreased IgA and increased IgE responses to the gut microbiota, reproduced following Treg cell-specific deletion of Rorc. We speculate that the presence of an anti-microbiota Th2 response may act to aggravate pathogenic immune responses to foods and may play a critical role in disease initiation, persistence and outcome.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41591-019-0461-z. Supplementary Fig. 1 summarizes the distribution of samples collected by subject age. One hundred and fifty-four subjects were enrolled, 56 (36%) with food allergies to at least one of the major food allergens including milk, soy, egg, tree nuts, fish, shellfish, wheat or peanuts, and 98 (64%) healthy controls. Seventy-eight percent of FA subjects were poly-sensitized, as defined by a positive skin test and/or specific IgE to at least two foods. Other FA included sesame, oat, pea, avocado, apple, grape and cantaloupe. Twenty-six FA infants (16.8%) were diagnosed with cow's milk allergy and were avoiding milk products at the time of stool sampling.
Healthy control subjects or subjects with FA aged 1-15 months were enrolled. FA criteria included a history of allergic reactions to one or more of the major food allergens (for example, milk, soy, egg, tree nuts, fish, shellfish, wheat or peanuts), such as urticaria, angioedema, wheezing, diarrhea, vomiting and moderate to severe eczema that was clearly triggered by food exposure and improving markedly after food avoidance; and a confirmatory positive food-specific skin prick test ≥3 mm compared to saline control and/ or serum food-specific IgE ≥0.35. Exclusion criteria included: (1) prematurity, defined as delivery before 37 weeks of gestation; (2) recurrent or chronic infections necessitating frequent systemic (including oral) antibiotic administration; (3) history of chronic immunosuppressive therapies; (4) history of gastroenterological conditions, including non-IgE-mediated colitis, eosinophilic esophagitis and food protein-induced enterocolitis, allergic colitis, GE reflux or constipation necessitating medication; and (5) history of other chronic diseases, excepting atopic conditions.
For studies on circulating ROR-γt + Treg and Teff cells, demographic details on the human subjects involve-including FA, atopic but not FA and healthy controls-are detailed in Supplementary Table 5 . The diagnosis of FA was ascertained as detailed in the above section. Subjects who were atopic but not FA carried a diagnosis of allergic rhinitis, asthma and/or eczema, as detailed in Supplementary Table 5 , while healthy control subjects did not have a history of FA or atopic diseases. All human subjects were recruited from the Boston Children's Hospital main and satellite sites in Massachusetts. All human studies were approved by the Institutional Review Board.
Sample collection. Parents were asked to collect stools from subjects every 4-6 months for up to 30 months of age, using a clean wood stick in Eppendorf tubes and RNA-later tubes (Thermo Fisher), and to freeze the sample in their home freezer immediately. Samples were collected from subjects' homes within 1-3 weeks of specimen collection. Overall, 60 subjects gave only one stool sample, 31 subjects gave two serial samples, 30 gave three samples, 17 gave four samples and 16 gave five samples. Each sample collection was spaced by 4-6 months. If systemic antibiotics were prescribed, sample collection was delayed for 4-6 weeks after the previous dose of antibiotic administered, as guided by published studies tracking the recovery of gut microbiota following antibiotic treatment 55, 56 . If a patient became tolerant to the food to which they were initially allergic (defined as being able to tolerate at least 4 g of protein of that food), subsequent samples were not included in the analysis unless the subject had a further FA confirmed by history and positive skin and/or specific IgE. Samples from sensitized patients lacking a confirmatory history of an allergic food reaction were excluded from analysis. Parents completed an online questionnaire with each stool collection that included information regarding diet, breastfeeding, age, FA, infection and use of antibiotics.
16S rDNA gene phylotyping. A multiplexed amplicon library covering the 16S rDNA gene V4 region was generated from human stool sample DNA as described 57 . Briefly, bacterial genomic DNA was extracted using the Mo Bio Power Fecal DNA Isolation kit (Mo Bio Laboratories) according to the manufacturer's instructions. To increase DNA yields, the following modifications were used. An additional bead beater step using the Faster Prep FP120 (Thermo) at 6 ms −1 for 1 min was used instead of vortex agitation. Incubation with buffers C2 and C3 was done for 10 min at 4 o C. Starting nucleic acid concentrations were determined by a Qubit Fluromoter (Life Technologies). The amplicon library was prepared using dual-index barcodes 57 . The aggregated library pool was size selected from 300-500 base pairs (bp) on a pippin prep 1.5% agarose cassette (Sage Sciences) according to the manufacturer's instructions. The concentration of the pool was measured by qPCR (Kapa Biosystems) and loaded onto the MiSeq Illumina instrument (300-bp kit) at 6-9pM with 40% phiX spike-in to compensate for low base diversity according to Illumina's standard loading protocol.
16S rDNA gene sequencing data preprocessing. Sequencing of the 16S rDNA amplicons from the 368 human stool samples generated 14,279,132 total raw reads, with a mean of 38,802 reads per sample. Raw sequencing reads were processed using the mothur software package (v.1.35.1) 58 and custom Python scripts, which perform de-noising, quality filtering, alignment against the ARB Silva reference database of 16S rDNA gene sequences, and clustering into OTUs at 97% identity. In total, 16,387 OTUs were generated. OTUs with extremely low abundance were filtered using the following parameters: removed if mean relative
Since the composition of the microbiota is known to change throughout childhood, we stratified subjects by age into six-month intervals (1-6, 7-12, 13-18, 19-24, and 25-30 months). This interval span was chosen to provide resolution with respect to age, while ensuring sufficient numbers of subjects in each group to support meaningful comparisons. Because insufficient numbers of subjects were available for the 30-36-month group, this group was omitted from our analyses. After stratifying subjects by age groups segregated at six-month intervals, 47, 53, 78, 74 and 79 OTUs were available after filtering in age groups 1-6 months, 7-12 months, 13-18 months, 19-24 months and 25-30 months, respectively. 16S rDNA gene sequencing data statistical analysis. To assess for differences in ecological (alpha) diversity, Shannon entropy was calculated for each sample with statistical testing using the Wilcoxon rank-sum test. To assess differences in overall microbial community structure, beta-diversity was calculated using the unweighted and weighted Unifrac measures with statistical testing by the analysis of molecular variance method [59] [60] [61] . To test statistically for differences in the relevant abundances of fecal microbiota OTUs between control and FA subjects, the DESeq2 software package was employed with an analysis design depicted in Supplementary Fig. 1 62, 63 . Key covariates of interest (gender, mode of delivery and breastfeeding only for those younger than 18 months) were controlled for using the multifactorial model in DESeq2. Since cow's milk protein (CMP) intake could directly alter the microbiota, and is highly correlated with FA status, we also performed a subset analysis removing subjects without CMP intake. P values were adjusted for multiple hypothesis testing using the method of Benjamini and Hochberg 64 . OTUs reported met the following criteria: (1) adjusted P ≤0.1 and (2) absolute value of log 2 fold change ≥2.
16S rDNA gene sequencing data phylogenetic analysis. To more accurately identify the micro-organisms present in samples and their phylogenetic relationships to known species, the pplacer software package was used to perform phylogenetic placement 65 . Pplacer uses a likelihood-based methodology to place short sequencing reads of 16S rDNA amplicons on a reference tree, and also generates taxonomic classifications of the short sequencing reads using a least common ancestor-based algorithm. The reference tree required for phylogenetic placement was generated using full-length or near full-length (>1,200 nt) 16S rDNA sequences of type strains from the Ribosomal Database Project
66
. In our studies, we report on the taxa that were phylogenetically placed with a like weight ratio of ≥0.8. The reminder of the taxa can be found in Supplementary Table 2 . For purposes of describing OTUs in the manuscript, we refer to the CRS to the phylogenetically placed consensus sequence for the OTU. While CRS does not represent an unambiguous species identification, it provides a point of reference for understanding microbiologically driven mechanisms in FA, and for deeper characterization using metagenomic or culture-based methods in future studies.
Mouse strains. The following mice with a BALB/c background have previously been described: BALB/cByJ (designated as WT mice), Rag2 . In all experiments, mice were matched for strain background.
Oral allergic sensitization of mice. Mice were subjected to oral allergic sensitization with OVA, mixed with SEB (Toxin Technology), as previously described 13, 24 . For antibiotic treatment, mice were treated with an antibiotic cocktail (Sigma-Aldrich) containing ampicillin (2.5 mgml ), administered by oral gavage in a final total volume of 100 µl PBS once daily for one week, as indicated. For Treg cell depletion with DT, mice were injected intraperitoneally with DT (Sigma-Aldrich) at 250 ngml -1 per injection per mouse (about 10 µgkg -1 ), as indicated. For treatment with anti-CD25 or isotype control mAbs (BioXCell), mice were injected intraperitoneally with the indicated antibody at 100 µg per injection per mouse, as indicated.
Percutaneous allergic sensitization of mice. Mice were treated with antibiotics for one week, as described above. They were then sensitized intradermally with OVA/ SEB as follows. The back was shaved then tape-stripped six times with Tegaderm dressings 46 . OVA/SEB (at a concentration of 5 mgml -1 OVA and 10 µg SEB in a final volume of 100 µl PBS) were applied directly to the skin. The sensitization was repeated twice weekly for five weeks. In subgroups of mice the Clostridiales consortium (see below) was given by gavage at 200 µl per mouse twice weekly for five weeks. At the end of the sensitization period, the mice are challenged with OVA with 150 mg 300 µl −1 of PBS per mouse via gavage.
Detection of fecal bacteria-bound IgA and IgE by flow cytometry. Fifty milligrams of fecal pellet was homogenized in 1 ml of cold, sterile PBS and centrifuged at 40g for 10 min at 4 ºC to remove large particles. Supernatant containing the bacteria was collected, filtered through a 70-µm strainer and centrifuged at 8,000g for 5 min to pellet the bacteria. The pellets were then washed twice with 1 ml of sterile PBS and incubated on ice for 15 min with blocking buffer (50% fetal calf serum (FCS) in PBS for human fecal samples and 50% FCS + 10 mgml −1 OVA in PBS for mouse fecal samples). Samples were centrifuged at 8,000g for 5 min and subsequently stained with 5 μM SYTO-BC (eBioscienceThermo Fisher) along with either anti-mouse IgA (clone mA-6E1, eBioscienceThermo Fisher) or anti-mouse IgE (clone RME-1, Biolegend). Similarly, human fecal samples were stained with 5 μM SYTO-BC along with either anti-human IgA (clone IS11-8E10, Miltenyi Biotech) or anti-human IgE (clone G7-26, BD Biosciences). Samples were then washed three times with 1 ml PBS before flow cytometric analysis on a BD LSR Fortessa.
Isolation of MLN and LP lymphocytes. MLNs were isolated and homogenized in PBS containing 2% FCS buffer. Cells were washed once with PBS containing 2% FCS and used for experiments. Small intestines were dissected from mice and the fecal contents were flushed out using PBS containing 2% FCS. Peyer's patches were excised and the intestines cut into 1-cm pieces and treated with PBS containing 2% FCS, 1.5 mM DTT and 10 mM EDTA at 37 °C for 30 min, with constant stirring to remove mucus and epithelial cells. The tissues were then minced and the cells dissociated in RPMI containing collagenase (2 mg ml Table 5 ) were stored at -80°C in microbank tubes (Pro-Lab Diagnostics). Obligately anaerobic species were plated from frozen stocks onto pre-reduced Brucella agar plates (BBL, Beckton Dickinson) and incubated in a Coy anaerobic chamber (Coy Labs). Facultative anaerobes were plated onto Trypticase Soy Agar (TSA) medium (Remel) and incubated in the Coy chamber. All plates were incubated until visible growth was detected. Purity of materials was confirmed by Gram stain and rapid ANA (Remel) panels for anaerobes, or by API-20E strips (Remel) for aerotolerant facultative species.
Growth curve studies in the appropriate liquid media (Supplementary  Table 4 ) were performed to quantitate a given biomass of organisms to the optical density (OD) measured at 600 nm. To prepare aggregate cultures, tubes containing 5 ml of the broth appropriate to supporting growth were inoculated. After visible growth and confirmation of culture purity, materials were then added to a larger culture volume to obtain additional biomass for aggregate mixtures. Cultures were staged based on the calculated time of the growth curves to enable processing of a maximum biomass of each species on the day aggregate materials would be prepared. The bacterial consortia were prepared by normalizing the bacterial components according to OD 600 so that the OD of each component was approximately the same as that of the other bacteria in the cocktail. Materials were aggregated to conatain approximately 5 × 10 7 colony-forming units (CFU) ml -1 of each organism. After preparation of each aggregate mixture, 1-ml aliquots were prepared in cryovials in a Coy anaerobic chamber, which were sealed, removed from the chamber and flash-frozen in liquid nitrogen. Prior studies had identified that flash-freezing by this method minimized loss of viable cells with the freeze-thaw to a ½ log-level or less 69 . Frozen aliquots were stored at −80°C until use. Representative aliquots were subjected to qPCR with the probes given in Supplementary Table 6 to confirm component species and relative abundance in the mixtures. Mixtures of obligate anaerobes were also plated aerobically to TSA agar media and incubated at 37 °C in 5% CO 2 for 72 h to confirm the absence of aerotolerant contaminants. The negative control consortium of members of the Proteobacteria was plated to CNA sheep's blood agar (Remel) incubated at 37 °C under anaerobic conditions, and at 5% CO 2 under aerobic conditions, for 72 h to confirm the absence of Gram-positive contaminants.
Preparation of S. variabile therapeutic. Microbiologic stocks of S. variabile (DSM 15176) were prepared as described. Maximal growth, ranging from 5 × 10 6 to × 10 7 CFUml −1 in liquid media, was observed at 72 h post-inoculation. For preparation of aliquots, a PRAS BHI tube (Thermo Fisher) was inoculated and incubated for 72 h at 37 °C in a Coy anaerobic chamber. Gram staining and culture to BHI medium were done to confirm purity. Next, 2.5 ml of the culture was added to separate 150-ml cultures of BHIS medium with hemin and vitamin K (Remel) and incubated in the anaerobic chamber for 72 h before preparation of aliquots. The strain lost substantive viability with attempts to concentrate its biomass under anaerobic conditions. Aliquots were thus prepared in a Coy chamber with nominal handling by transferring 1-ml aliquots of the 72-h culture into cryovials and sealing them in the chamber. Aliquots were then removed and snap-frozen on liquid nitrogen for storage at −80 °C until use. Separate aliquots were serially diluted and plated to BHI, with counting of pinpoint-sized colonies at 72 h to confirm S. variabile and at a biomass of 1.2 × 10 7 CFUml −1 for administration of 2.4 × 10 6 CFU per mouse in 200 µl.
Heat killing of therapeutic consortia. Sealed aliquots of the Clostridial or Bacteroidales consortia were placed in a heating block at 85 °C for 1 h to kill vegetative cells and spores. Control aliquots were transferred to a Coy anaerobe chamber and plated to BHI agar and broth with hemin and vitamin K to confirm killing by absence of growth. The Clostridiales consortium was also inoculated into BHI broth media + 1% maltose, hemin and vitamin K to confirm killing of C. leptum. No heat-killed aliquots demonstrated any signs of growth. Heat-treated aliquots were then used in studies to assess the efficacy of preparations lacking viable bacteria.
SCFA analyses. Samples of gut contents were kept frozen at -80 °C until analysis. The samples were removed from the freezer and thawed; 500 µl of highperformance liquid chromatography water was added to each sample, vortexed for 10 min and centrifuged at 5,000g for 10 min; 400 µl of the clear supernatant was then transferred to a 2.0-ml Eppendorf tube. The pH of each sample was adjusted to 2-3 by the addition of 50 µl of 50% sulfuric acid, followed by 50 µl of the internal standard (1% 2-methyl pentanoic acid solution) and 400 µl of anhydrous ethyl ether (Sigma-Aldrich). The tubes were mixed end over end for 10 min and then centrifuged at 2,500g for 2 min. The upper ether layer was transferred to an Agilent sampling vial for analysis, then 1 µl of the upper ether layer was injected into the chromatogram for analysis.
Chromatographic analysis was carried out using an Agilent 7890B system with a flame ionization detector (FID) (Agilent Technologies). A high-resolution gas chromatography capillary column (30 m × 0.25 mm) coated with film of thickness 0.25 um was used (DB-FFAP) for the volatile acids (Agilent Technologies). Nitrogen was used as the carrier gas. The oven temperature was 145 °C and the FID and injection port were set to 225 °C. The injected sample volume was 1 µl and the run time for each analysis was 12 min. Chromatograms and data integration were carried out using the OpenLab ChemStation software (Agilent Technologies).
Standard solutions.
A volatile acid mix containing 10 mM each of acetic, propionic, isobutyric, butyric, isovaleric, valeric, isocaproic, caproic and heptanoic acids was used (Supelco/Sigma-Aldrich). A standard stock solution containing 1% 2-methyl pentanoic acid (Sigma-Aldrich) was prepared as an internal standard control for extraction of volatile acids.
Quantification of acids.
Four hundred microliters of the standard mix was used and the extracts prepared as described for the samples, except that 400 µl of ethyl ether was added. The retention times and peak heights of acids in the standard mix were used as references for the sample unknowns. These acids were identified by their specific retention times, and the concentrations determined and expressed as mM gram ; Sigma-Aldrich) and ionomycin (500 ngml
; Sigma-Aldrich) in the presence of Golgi Plug (BD Biosciences), then stained with BD Cytofix/ Cytoperm buffers (BD Biosciences) and the indicated anti-cytokine antibody. For intracellular staining of nuclear factors, the Foxp3 Transcription Factor buffer set (eBioscience) was used. Dead cells were routinely excluded from the analysis based on staining by eFluor 506 fixable viability dye (eBioscience), and analyses were restricted to single cells using FSC-H and FSC-A signals. Stained cells were analyzed on an LSR Fortessa (BD Biosciences) and data were processed using Flowjo (Tree Star Inc.).
ELISA.
Total, OVA-specific IgE and MMCP-1 concentrations were measured in the sera of treated mice by ELISA, as previously described 13 .
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Histology. Intestinal mast cells were counted by microscopic examination of jejunal sections fixed in 10% formaldehyde and stored in 70% ethanol before staining with toluidine blue by the Harvard Rodent Histopathology Facility.
Statistical analysis. Anaphylaxis-related core body temperature measurements were analyzed using repeat measures two-way ANOVA with the indicated post-test analysis. Student's unpaired two-tailed t-tests were used for two-group comparisons. For more than two groups, one-way ANOVA with the indicated post-test analysis was used. Results are presented as means and s.e.m., where each point represents one sample. In cases in which values were spread across multiple orders of magnitude, data were log-transformed for analysis by parametric testing.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Data presented in the manuscript, including de-identified patient results, will be made available to investigators following request. All requests for raw and analyzed data and materials will be promptly reviewed by the Boston Children's Hospital Technology & Innovation Development Office to verify whether the request is subject to any intellectual property or confidentiality obligations. Any data and materials that can be shared will be released via a Material Transfer Agreement. The 16S bacterial rRNA datasets generated in the course of this project have been deposited at the National Center for Biotechnology Information Sequence Read Archive under BioProject ID: PRJNA525231. Detailed age and disease attributes of the deposited BioProject sample data will be made available on request. 
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